Natus Medical Is All Grown Up
This baby has a new ticker.
Natus Medical
NTUS
NTUS
$32.86
$0.51
1.6%
BATS BZX Real Time Price as of October 18, 2019, 4:00 p.m. EDT
View Interactive NTUS Charts
A provider of healthcare products used for screening, detection, treatment, monitoring & tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, newborn jaundice & newborn metabolic testing.
News & Analysis: Natus Medical
The Fool has written over 100 articles on Natus Medical.
Natus Medical Inc (BABY) Q2 2019 Earnings Call Transcript
BABY earnings call for the period ending June 30, 2019.
Natus Medical Continues Its Restructuring
It's a rebuilding year for the medical device maker.
Natus Medical Inc (BABY) Q1 2019 Earnings Call Transcript
BABY earnings call for the period ending March 31 2019.
1 Surprising Reason Alzheimer's Drugs Remain So Elusive
Most biotech drugs focus on clearing plaques from brain cells, but restoring patients' sleep quality is also proving to be necessary.
Why Natus Medical Stock Dropped 18.1% in February
It wasn't just lower-than-expected earnings that hurt the medical device company.
Natus Has Some Growing Up to Do
2019 will be a rebuilding year for the neurology and newborn-care specialist.
Natus Medical Inc. (BABY) Q4 2018 Earnings Conference Call Transcript
BABY earnings call for the period ending December 31, 2018.
Here's Why Natus Medical Is Having a Bad Day
The company's softer-than-expected outlook wasn't what investors wanted to see.
Natus Medical Takes Baby Steps Forward
Another lackluster quarter, but the medical device maker is trying to turn things around.
![natusnewbornscreening_large1_large1_large1_large[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F200902%2Fnatusnewbornscreening_large1_large1_large1_large1.png&w=479&h=281&op=resize)
